Siegfried Holding
Charles Blanloeil is a Lab Application Specialist at Siegfried, with previous experience as an Ingénieur consultant CSV at agap2 Switzerland and various roles in quality control and validation at Universal Medica Group and SEQENS Pharmaceutical Solutions. Charles has a diverse background, including interim positions in events such as the Escape game at the Opéra Garnier and the Toutankhamon exhibition, and research experience at Institut Pasteur focusing on Listeria virulence factors. Charles holds a Mastère spécialisé in Management par la qualité from KEDGE Business School, a Master's degree in Biologie Santé with a focus on Biomatériaux for health from CY Cergy Paris Université, and a Bachelor's degree in general biology from the same institution.
Siegfried Holding
1 followers
Siegfried Holding AG is a Switzerland-based life sciences company and active in primary and secondary drug manufacturing. The Company produces both drug substances and drug products. The drug substance portfolio includes contract development and manufacturing of both active pharmaceutical ingredients (APIs) and intermediates. The drug products portfolio comprises licensing and contract or co-development and manufacturing of oral solids and steriles. The Company's products and substances are developed for treatment of hypertension, benign prostate hyperplasia, depression, chronic myeloid leukemia, glaucoma, asthma, schizophrenia and bipolar disorders and diabetes. The Company operates production facilities in Switzerland, Germany, France, Malta, the United States and China.